These compounds may interact with:
Prolyl endopeptidase
Potentially involved in: carcinoma; hypotonia-cystinuria syndrome; amnestic disorder; celiac disease; fetal valproate syndrome; alzheimer's disease; amnesia; retrograde amnesia; bipolar disorder; stomach neoplasms; manic; atypical teratoid / rhabdoid tumor; intraductal papillary-mucinous adenoma (ipma); intraductal papillary-mucinous carcinoma (ipmc); intraductal papillary-mucinous neoplasm (ipmn); medulloblastoma; medulloblastoma, large-cell; osteosarcoma; ovarian cancer; psoriasis
Disease data sourced from Pharos.